Part 1: background, methodology, and clinical adoption of pharmacogenetics.
about
Lung cancer biomarkers, targeted therapies and clinical assaysShould Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?Clinically relevant cancer biomarkers and pharmacogenetic assays.Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.Application of genotype-guided cancer therapy in solid tumors.Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia.SNPs and taxane toxicity in breast cancer patients.
P2860
Q26775396-16AB086B-CE10-4CFC-A958-003263D92EDDQ35981408-A01EEF51-D445-43A4-A619-B2467F17520BQ38077041-5468CEB7-1319-489B-A2DB-AE8047736442Q38082728-63E59DE5-92BC-4456-872D-1844C6396CA8Q38170457-003A7B75-BCEC-4EFC-859E-30925AAC2A1AQ41469853-2977BD1C-353F-462C-BD8D-D0D53DE00D47Q46800256-219BF69D-3AAD-4D1C-9402-60C08C9D0124
P2860
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
@en
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
@nl
type
label
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
@en
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
@nl
prefLabel
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
@en
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
@nl
P2093
P2860
P1433
P1476
Part 1: background, methodology, and clinical adoption of pharmacogenetics.
@en
P2093
Annemieke Cats
Jan H M Schellens
Jos H Beijnen
Maarten J Deenen
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0258
P577
2011-05-31T00:00:00Z